Explore the words cloud of the MD-SD-OCT project. It provides you a very rough idea of what is the project "MD-SD-OCT" about.
The following table provides information about the project.
COSTRUZIONI STRUMENTI OFTALMICI C.S.O. SRL
|Coordinator Country||Italy [IT]|
|Total cost||1˙965˙867 €|
|EC max contribution||1˙965˙867 € (100%)|
1. H2020-EU.3.1.3. (Treating and managing disease)
|Duration (year-month-day)||from 2015-06-01 to 2017-05-31|
Take a look of project's partnership.
|1||COSTRUZIONI STRUMENTI OFTALMICI C.S.O. SRL||IT (BADIA A SETTIMO)||coordinator||1˙965˙867.00|
It has been observed that eye related disease such Keratoconus, glaucoma and cataract are recently increased, especially in older adult, which are commonly more prone to this kind of pathology, with a significant rise also in young adults subject, due to nowadays lifestyle. The first main objective of CSO business project is to introduce into the market the innovative MD-SD-OCT, a new ophthalmology instrument, which is able to detect, with a single tool, a range of optical pathologies wider than the state of the art technologies are capable to support, with higher performances and significant reduction of manufacturing cost. This target will be reached through the integration of traditional topography approach (Placido's disk) and innovative patented Spectral Domain Optical Coherence Tomography (ref. WO 2014/155286 A1), into a single, compact and flexible diagnosis device, real breakthrough for the market at the state of art. As a results of the technology innovation proposed and due to the usage of a less expensive technology invented by CSO (new SD-OCT management system, covered by international patent), the overall cost of the device is significantly lower than the existing applicable technology (about 45% less). This aspect will be the most disruptive and distinguishing element of the entire business project and will determine a huge increase of the company competitiveness. As a result of intensive market need research, performed by the company in the last two years, and thanks to its expertise in R&D for design and manufacturing of innovative ophthalmology diagnosis devices, CSO, with higher performance , significantly lower cost and new double technology MD-SD-OCT will be able to strongly improve its competitiveness in the market of ophthalmology diagnosis devices.
|Website release||Demonstrators, pilots, prototypes||2019-07-24 14:45:54|
|Circulation of periodic press releases and publications of articles||Demonstrators, pilots, prototypes||2019-07-24 14:45:54|
Take a look to the deliverables list in detail: detailed list of MD-SD-OCT deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MD-SD-OCT" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "MD-SD-OCT" are provided by the European Opendata Portal: CORDIS opendata.
CeLac and European consortium for a personalized medicine approach to Gastric CancerRead More
PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregiversRead More
ENDOSCAPE, a clinically applicable non-viral gene delivery technologyRead More